CoChat

A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR

Vanden Berghe, Wim, Vermeulen, Linda, Delerive, Philippe, De Bosscher, Karolien, Staels, Bart, Haegeman, Guy · 2003 · Advances in experimental medicine and biology

The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

The onset of inflammatory gene expression is driven by the transcription factor NF-kappaB, whose transcriptional activity is regulated at multiple levels. First, NF-kappaB activity is regulated by cytoplasmic degradation of the IkappaB inhibitor and nuclear translocation. Second, the nuclear p65 transactivation potential can be further influenced by posttranslational modifications, such as phosphorylation and/or acetylation. The p65 phosphorylation is a process highly regulated by both cell- and stimulus-dependent activating kinases. Ser276 phosphorylation seems to be highly important considering its crucial role in the interaction with and the engagement of the cofactor CBP/p300. We have identified MSK1 as an acting kinase in the TNF-signalling pathway, where it is responsible for p65 phosphorylation at Ser276, as well as for H3 phosphorylation of Ser10 in IL-6 promoter-associated chromatin (Fig. 1) (Saccani et al., 2002; Vermeulen et al., 2002, 2003). To our knowledge, this was the first report that identifies one particular kinase involved in transcription factor phosphorylation and histone modification at the level of a single promoter in order to establish gene activation. The question of which element takes the initial step to recruit and to assemble the activated transcription complex still remains unanswered (Vanden Berghe et al., 2002). PPAR alpha negatively interferes with inflammatory gene expression by up-regulation of the cytoplasmic inhibitor molecule IkappaB alpha, thus establishing an autoregulatory loop (Fig. 1). This induction takes place in the absence of a PPRE, but requires the presence of NF-kappaB and Sp1 elements in the IkappaB alpha promoter sequence as well as DRIP250 cofactors. The detailed mechanism how PPAR can activate genes in a non-DNA-binding way needs further investigation; moreover, it is at present not clear whether this upregulation, unlike the inhibitory effect of glucocorticoids, is a cell type- or a PPAR-specific phenomenon.

Overview

Integrity signals

Registry

Crossref · 10.1007/978-1-4419-9072-3_22

Cites

108 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 109 references

Research works printed but not linked: 21

  1. Delerive, P., Gervois, P., Fruchart, J. C, and Staels, B., 2000, Induction of IkBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators.J. Biol. Chem.275:36703–36707. · DOI · Paper page
  2. Deng, W. G., Zhu, Y., and Wu, K. K., 2003, Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-a-induced cyclooxygenase-2 promoter activation.J. Biol. Chem.278:4770–4777. · DOI · Paper page
  3. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W., 1996, The PPARa-leukotriene B4 pathway to inflammation control.Nature384:39–43. · DOI · Paper page
  4. Dixit, V., and Mak, T. W., 2002, NF-kB signaling. Many roads lead to Madrid.Cell111:615–619. · DOI · Paper page
  5. El Kharroubi, A., Piras, G., Zensen, R., and Martin, M. A., 1998, Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.Mol. Cell. Biol.18:2535–2544. · DOI
  6. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., 1997, CREB- binding protein/p300 are transcriptional coactivators of p65.Proc. Natl. Acad. Sci. USA94:2927–2932. · DOI · Paper page
  7. Ghosh, S., and Karin, M., 2002, Missing pieces in the NF-kB puzzle.Cell109:S81–96. · DOI · Paper page
  8. Giles, R. H., Peters, D. J., and Breuning, M. H., 1998, Conjunction dysfunction: CBP/p300 in human disease.Trends Genet.14:178–183. · DOI · Paper page
  9. Gilmore, T. D., 1999, The Rel/NF-KB signal transduction pathway: introduction.Oncogene18:6842–6844. · DOI · Paper page
  10. Glass, C. K., and Rosenfeld, M. G., 2000, The coregulator exchange in transcriptional functions of nuclear receptors.Genes Dev.14:121–141. · DOI · Paper page
  11. Gu, W., and Roeder, R. G., 1997, Activation of p53 sequence-specific DNA binding by acetyl-ation of the p53 C-terminal domain.Cell90:595–606. · DOI · Paper page
  12. Hampsey, M., and Reinberg, D., 1999, RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev.9:132–139. · DOI
  13. Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., and Beyaert, R., 1999, The zinc finger protein A20 inhibits TNF-induced NF- KB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-KB-inhibiting protein ABIN.J. Cell Biol.145:1471–1482. · DOI · Paper page
  14. Holloway, A. F., Rao, S., Chen, X., and Shannon, M. F., 2003, Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kB proteins.J. Exp. Med.197:413–423. · DOI
  15. Hong, S. H., Wong, C. W., and Privalsky, M. L., 1998, Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressorMol. Endocrinol. 12:1161–1171. · DOI · Paper page
  16. Huang, T. T., Kudo, N., Yoshida, M, and Miyamoto, S., 2000, A nuclear export signal in the N- terminal regulatory domain of IkBoc controls cytoplasmic localization of inactive NF-KB/IicBa complexes.Proc. Nad. Acad. Sci. USA97:1014–1019. · DOI · Paper page
  17. Dceda, K., Steger, D. J., Eberharter, A., and Workman, J. L., 1999, Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes Mol. Cell. Biol. 19:855–863. · DOI
  18. Israel, A., 2000, The IKK complex: an integrator of all signals that activate NF-kB?Trends Cell Biol.10:129–133. · DOI · Paper page
  19. Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S., 1994, Three NF-kB sites in the IkB-o, promoter are required for induction of gene expression by TNF a.Nucleic Acids Res.22: 3787–3792. · DOI · Paper page
  20. Jacobson, S., and Pillus, L., 1999, Modifying chromatin and concepts of cancer.Curr. Opin. Genet. Dev.9:175–184. · DOI
  21. Wajant, H., Pfizenmaier, K., and Scheurich, P., 2003, Tumor necrosis factor signaling. Cell Death Differ. 10,45–65. · DOI · Paper page

Cited by

See all 231

Metadata

Authors
Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G.
Affiliations
  • Ghent University (BE)
  • Inserm (FR)
Venue
Advances in experimental medicine and biology
Publisher
Springer US
Published
2003
Volume
544
Pages
181-196
ISSN
0065-2598 (ISSN-L)
OpenAlex
W1506249422
Cited by
222
References
105
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 14 · 2020: 17 · 2019: 8 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 17 · 2012: 15
FWCI
4.51
Type
book chapter
Language
en
Open access
closed
Locations
  • Advances in experimental medicine and biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
NF-κB, PPARα, inflammation, inflammatory gene expression, IκBα, p65 phosphorylation, CBP/p300, histone H3 Ser10 phosphorylation, IL-6 promoter, chromatin, Sp1, transcriptional regulation, autoregulatory loop, glucocorticoids
MeSH terms
Animals, Gene Expression Regulation, Humans, Inflammation, Models, Biological, Transcription Factors, Transcriptional Activation, Interleukin-6, NF-kappa B, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, MAP Kinase Signaling System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR. https://app.cochat.ai/papers/10.1007/978-1-4419-9072-3_22
The paper
Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G. (2003). A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR. Advances in experimental medicine and biology. https://doi.org/10.1007/978-1-4419-9072-3_22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.